Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.

Source:http://linkedlifedata.com/resource/pubmed/id/15755991

Clin. Cancer Res. 2005 Mar 1 11 5 1704-12

Download in:

View as

General Info

PMID
15755991